Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Random Allocation × Breast × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 NET 1 Lymphoid 1 Gynecologic 1 Gastrointestinal 1 Endocrine 1 Breast 1

Conditions

Breast Neoplasms 1

Interventions

Trastuzumab 601 Paclitaxel 590 Cyclophosphamide 552 Docetaxel 490 Capecitabine 426 Letrozole 353 Carboplatin 337 Fulvestrant 328 Doxorubicin 290 Tamoxifen 255 pembrolizumab 234 Anastrozole 212 Epirubicin 211 exemestane 201 Radiotherapy 194 Bevacizumab 192 pertuzumab 187 Gemcitabine 183 Vinorelbine 170 Lapatinib 162 palbociclib 154 130-nm albumin-bound paclitaxel 146 Albumin-Bound Paclitaxel 137 Magnetic Resonance Spectroscopy 133 Exercise 127 eribulin 126 Fluorouracil 114 Taxes 113 Everolimus 102 Cisplatin 101

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02590315 2019-01-31

ProteusDonna

Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Phase 4 Unknown

92,000 enrolled

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡